Your browser doesn't support javascript.
loading
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study.
Kafka, Mona; Horninger, Andreas; di Santo, Gianpaolo; Virgolini, Irene; Neuwirt, Hannes; Unterrainer, Lena M; Kunte, Sophie C; Deiss, Emil; Paffenholz, Pia; Heidenreich, Axel; Rasul, Sazan; Einspieler, Holger; Shariat, Shahrokh F; Rajwa, Pawel; Dozauer, Robert; Tsaur, Igor; Medlock, Ellen; Rölz, Niklas; Rausch, Steffen; la Fougère, Christian; Trautwein, Nils; Roesch, Marie C; Merseburger, Axel S; Zattoni, Fabio; Sepulcri, Matteo; Ladurner, Michael; Bektic, Jasmin; Gandaglia, Giorgio; Horninger, Wolfgang; Heidegger, Isabel.
Afiliación
  • Kafka M; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • Horninger A; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • di Santo G; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Virgolini I; Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Neuwirt H; Department of Internal Medicine IV - Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
  • Unterrainer LM; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Kunte SC; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Deiss E; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Paffenholz P; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Rasul S; Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
  • Einspieler H; Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Weill Cornell Medicine, New York, NY, USA; Department of Urology, Second Faculty of Medicine, Charles Un
  • Rajwa P; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Dozauer R; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Tsaur I; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Medlock E; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Rölz N; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.
  • Rausch S; Department of Urology, University Hospital Tübingen, Tübingen, Germany.
  • la Fougère C; Department of Nuclear Medicine University Hospital Tübingen, Tübingen, Germany.
  • Trautwein N; Department of Nuclear Medicine University Hospital Tübingen, Tübingen, Germany.
  • Roesch MC; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Merseburger AS; Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Zattoni F; Department Surgery, Oncology and Gastroenterology, Urologic Unit, University of Padova, Padova, Italy.
  • Sepulcri M; Radiation Oncology Unit, Veneto Institute of Oncology IRCCS, Padua, Italy.
  • Ladurner M; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • Bektic J; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • Gandaglia G; Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Laboratory, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Horninger W; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • Heidegger I; Department of Urology, Medical University Innsbruck, Innsbruck, Austria. Electronic address: isabel-maria.heidegger@i-med.ac.at.
Eur Urol Oncol ; 2023 Aug 19.
Article en En | MEDLINE | ID: mdl-37604763
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Eur Urol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Austria